Results 1 to 10 of about 32,020 (156)
The Pulmonary Hypertension Global Patient Survey: Groups 2 and 3. [PDF]
ABSTRACT In this first global study of patient perspectives in Group 2 and 3 PH, we demonstrate that those with Group 3 PH report significantly greater adverse impacts on physical and mental wellbeing than those in Group 2 or Group 1, despite a lower treatment side‐effect profile.
Bunclark K +17 more
europepmc +2 more sources
The Pulmonary Hypertension Global Patient Survey: Physical and Psychosocial Impacts on Health-Related Quality of Life. [PDF]
ABSTRACT The Pulmonary Hypertension (PH) Global Patient Survey provides the first truly international description of the symptomatic burden of PH and its treatment on patient's health‐related quality of life (HRQoL). From 3329 adult responses across 88 countries, the “invisible” nature of PH is an over‐arching theme, with repercussions on socialisation,
Bunclark K +17 more
europepmc +2 more sources
The Vascular-Immune Cells Crosstalk and Microenvironment in Pulmonary Hypertension. [PDF]
This review synthesizes current evidence showing how vascular–immune cell crosstalk and microenvironmental cues shape pulmonary vascular remodeling in pulmonary hypertension. We provide an integrative perspective that positions disrupted cellular communication as a central driver of disease progression and a promising source of future therapeutic ...
Navarro-Llinares L +3 more
europepmc +2 more sources
Characterization of the Population With Intermediate-Risk Status in Pulmonary Arterial Hypertension: Patients in a Latin American Country: The CAPRI Registry. [PDF]
ABSTRACT Pulmonary arterial hypertension (PAH) in intermediate‐risk patients poses a challenge for clinicians, particularly in determining the optimal timing for escalating pharmacological treatment. We conducted a multicenter cross‐sectional study that analyzed data from the Colombian Pulmonary Hypertension Network (HAPredCO) on patients diagnosed ...
Conde-Camacho R +11 more
europepmc +2 more sources
Introducción: La confiabilidad de la presión sistólica arterial pulmonar por ecocardiografía transtorácica se encuentra limitada por su variabilidad para definir la hipertensión pulmonar. Objetivo: Conocer la variabilidad en la presión sistólica arterial
Diana Romero-Zertuche +4 more
doaj +1 more source
Objetivo: Describir las características epidemiológicas y clínicas, la evolución y el tratamiento de los pacientes con hipertensión arterial pulmonar.
Marcos Pariona +2 more
doaj +1 more source
Objetivos. El objetivo del estudio fue describir las características clínicas y la relación entre la severidad de la hipertensión arterial pulmonar (HAP) y el grado de insuficiencia renal. Materiales y métodos.
Franklyn Colón +5 more
doaj +1 more source
El seguimiento clínico de la hipertensión arterial pulmonar en nuestro país, en el que los pacientes proceden de distintas altitudes sobre el nivel del mar, nos obliga a descartar hipertensión pulmonar en relación con la exposición crónica a grandes ...
Enrique Saúl Sanabria Pérez +2 more
doaj +1 more source
Abstract figure legend Potassium channel subfamily K member 3 (KCNK3) is functionally expressed in pulmonary vascular and cardiac cells. KCNK3 loss of function and expression leads to pulmonary arterial hypertension (PAH) and right ventricular failure (RVF).
Anaïs Saint‐Martin Willer +8 more
wiley +1 more source
Graphical Abstract and Lay Summary The development of functional blood vessels today is a fundamental pillar in the evaluation of new therapies and diagnostic agents to treat pulmonary hypertension. In this study, a rotary incubation system has been used to ensure the homogeneous adhesion of endothelial cells in the walls of a tubular device fabricated
Oihane Mitxelena‐Iribarren +9 more
wiley +1 more source

